Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Jul 29, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0000899243-21-030664.pdf 0000899243-21-030664.rtf 0000899243-21-030664.xls
Jul 29, 2021	EFFECT	EFFECT	View HTML 9999999995-21-002977.pdf 9999999995-21-002977.rtf 9999999995-21-002977.xls
Jul 28, 2021	Pre-effective amendment to an S-4 filing	S-4/A	View HTML 0001193125-21-227574.pdf 0001193125-21-227574.rtf 0001193125-21-227574.xls
Jul 28, 2021	CORRESP	CORRESP	View HTML 0001193125-21-227578.pdf 0001193125-21-227578.rtf 0001193125-21-227578.xls
Jul 19, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0001346302-21-000066.pdf 0001346302-21-000066.rtf 0001346302-21-000066.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 12, 2021	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000834237-21-008770.pdf 0000834237-21-008770.rtf
Jul 09, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-008506.pdf 0000000000-21-008506.rtf
Jul 02, 2021	Report of unscheduled material events or corporate event	S-4	View HTML S-4.pdf 2.8 MB S-4.doc 9.3 MB S-4.xls 3.5 MB
Jul 02, 2021	Registration of securities issued in business combination transactions	S-4	View HTML 0001193125-21-207600.pdf 0001193125-21-207600.rtf 0001193125-21-207600.xls
Jun 08, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0001346302-21-000052.pdf 0001346302-21-000052.rtf 0001346302-21-000052.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.